Driehaus Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $301K | Sell |
677
-431
| -39% | -$192K | ﹤0.01% | 399 |
|
|
2025
Q1 | $537K | Sell |
1,108
-14
| -1% | -$6.79K | 0.01% | 368 |
|
|
2024
Q4 | $452K | Sell |
1,122
-47
| -4% | -$18.9K | ﹤0.01% | 359 |
|
|
2024
Q3 | $544K | Hold |
1,169
| – | – | ﹤0.01% | 341 |
|
|
2024
Q2 | $548K | Buy |
1,169
+235
| +25% | +$110K | 0.01% | 329 |
|
|
2024
Q1 | $390K | Sell |
934
-1,195
| -56% | -$500K | ﹤0.01% | 356 |
|
|
2023
Q4 | $866K | Buy |
2,129
+441
| +26% | +$179K | 0.01% | 320 |
|
|
2023
Q3 | $587K | Hold |
1,688
| – | – | 0.01% | 346 |
|
|
2023
Q2 | $594K | Buy |
+1,688
| New | +$594K | 0.01% | 335 |
|
|
2018
Q1 | – | Sell |
-2,088
| Closed | -$313K | – | 598 |
|
|
2017
Q4 | $313K | Sell |
2,088
-475
| -19% | -$71.2K | 0.01% | 462 |
|
|
2017
Q3 | $390K | Buy |
+2,563
| New | +$390K | 0.02% | 421 |
|
|
2015
Q4 | – | Sell |
-4,139
| Closed | -$431K | – | 614 |
|
|
2015
Q3 | $431K | Buy |
+4,139
| New | +$431K | 0.02% | 425 |
|